Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-06
1996-02-20
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514313, 514314, 546155, 546156, 546157, 546159, 546162, 546167, 546169, 546173, 546175, 546176, 546177, 546179, 546180, A61K 3147, C07D21514, C07D215227, C07D21538
Patent
active
054929156
ABSTRACT:
This invention relates to compounds having selective LTB.sub.4 antagonist properties. Therapeutic compositions comprising said compounds and methods for the treatment of disorders involving LTB.sub.4 agonist-mediated activity utilizing said compositions wherein the compounds are described by the formula ##STR1## wherein R.sub.4, X, R, Y, R', Q, m and n are herein defined, and pharmaceutically acceptable salts thereof.
REFERENCES:
Kaihara et al., Arch. Biochem., Biophys. 110(2), 316-19 (1965).
Dereu Norbert
Hendel Wolfram
Labaudiniere Richard
Henley III Raymond
Nicholson James A.
Parker III Raymond S.
Rhone-Poulenc Rorer S.A.
Savitzky Martin F.
LandOfFree
Substituted quinolyl compounds exhibiting selective leukotriene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinolyl compounds exhibiting selective leukotriene , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinolyl compounds exhibiting selective leukotriene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1356037